JOSLIN DIABETES CENTER, INC AND SUBSIDIARY: Single Audit Reports and Findings

JOSLIN DIABETES CENTER, INC AND SUBSIDIARY's most recent single audit in the Federal Audit Clearinghouse covers fiscal year 2021, accepted February 1, 2022; the auditor observed on that filing is Grant Thornton LLP. It reported no findings. 6 filings from 2016 to 2021 are on record. Data as of 2026-11-06.

Data as of Nov 6, 2026 · Source: Federal Audit Clearinghouse (public data)

Single audits by year

One row per audit year as the Federal Audit Clearinghouse accepted it. The auditor named is the one observed on that filing; JOSLIN DIABETES CENTER, INC AND SUBSIDIARY is recorded in BOSTON, Massachusetts under EIN 042203836, and the Clearinghouse records it as a nonprofit. Each report opens on the Clearinghouse itself; how to search the Federal Audit Clearinghouse explains the rest of the reporting package.

Single audits filed by JOSLIN DIABETES CENTER, INC AND SUBSIDIARY
Audit yearFiscal year endFederal expendedThreshold appliedAuditor observedOpinionFindingsMW / SDFAC report
20212021-09-30$22,556,439$750,000Grant Thornton LLPUnmodified0—2021-09-CENSUS-0000002854
20202020-09-30$20,828,892$750,000Grant Thornton LLPUnmodified0—2020-09-CENSUS-0000002854
20192019-09-30$24,288,868$750,000Grant Thornton LLPUnmodified0—2019-09-CENSUS-0000002854
20182018-09-30$24,777,481$750,000Grant Thornton LLPUnmodified0—2018-09-CENSUS-0000002854
20172017-09-30$24,378,280$750,000Grant Thornton LLPUnmodified0SD2017-09-CENSUS-0000002854
20162016-09-30$27,846,177$750,000KPMG LLPUnmodified0—2016-09-CENSUS-0000002854

When is the next single audit due?

If JOSLIN DIABETES CENTER, INC AND SUBSIDIARY is again required to have a single audit for the fiscal year ending Sep 30, 2022, the reporting package is due to the Federal Audit Clearinghouse by Jun 30, 2023 at the latest.

No filing for that fiscal year appears in the Clearinghouse data as of Nov 6, 2026. The data does not show why: an organization below the threshold is not required to file, and a filing can be accepted after the due date.

Whether an audit is required depends on federal awards expended in that year (the single audit threshold). The rule, 2 CFR 200.512(a): the reporting package is due within 30 calendar days after the auditee receives the auditor's report or nine months after the end of the audit period, whichever is earlier; the date above is the nine-month date, moved to Monday when it falls on a weekend. Last verified: 2026-11-15.

Which federal programs did this organization report?

From the most recent accepted report, as listed on its schedule of expenditures of federal awards (SEFA). "Major" is the designation the auditor made under 2 CFR 200.518, not ours.

Federal programs on the most recent report
ALNProgramExpendedMajor
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$13,929,423Yes
93.351RESEARCH INFRASTRUCTURE PROGRAMS$573,318Yes
93.837CARDIOVASCULAR DISEASES RESEARCH$535,613Yes
93.853EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$525,784Yes
93.310TRANS-NIH RESEARCH SUPPORT$441,753Yes
93.866AGING RESEARCH$436,400Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$377,091Yes
12.420MILITARY MEDICAL RESEARCH AND DEVELOPMENT$376,963Yes
93.498PROVIDER RELIEF FUND$351,551Yes
93.865CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH$318,686Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$306,782Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$301,643Yes
93.839BLOOD DISEASES AND RESOURCES RESEARCH$284,207Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$282,398Yes
93.867VISION RESEARCH$247,782Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$245,462Yes
93.867VISION RESEARCH$241,378Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$191,057Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$190,936Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$177,479Yes
93.867VISION RESEARCH$166,940Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$164,039Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$159,772Yes
93.853EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$155,861Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$143,810Yes

What findings did the auditor report?

The reference is the auditor’s; the requirement is the Compliance Supplement category the auditor selected. The finding text itself is not reproduced here; the FAC report linked above carries it in full. What the two severity levels mean: material weakness vs significant deficiency.

The most recent report lists no finding.

Form 990 and IRS registration

Form 990 "accounting fees" (Part IX line 11c) cover all accounting services reported by the organization and are not the price of an audit engagement.

Where to find the return itself, and what our Form 990 data covers: Form 990 lookup.

Most recent return
990 for 2025-09
Total revenue
$77,259,482
Total assets
$182,656,365
Accounting fees (Part IX line 11c)
$815
Paid preparer
DELOITTE TAX LLP
IRS object id
202622269349302342
NTEE code
G800
Exempt under
501(c)(3)
Ruling year
1961
BMF release
2026-10-20

Read next

How we computed this

Every row comes from the Federal Audit Clearinghouse record named beside it, one report per audit year, with a resubmission superseding the filing it replaces. The auditor is the one named on that filing — it is not a statement about who audits JOSLIN DIABETES CENTER, INC AND SUBSIDIARY now. Form 990 figures come from the IRS e-filed return named by its object id. This page exists because the organization filed at least two single audits, or one with a finding.

Cite this page

AuditRadar. “Joslin Diabetes Center, Inc and Subsidiary Single Audit FY2021.” https://getauditradar.com/single-audits/ma/joslin-diabetes-center-inc-and-subsidiary-042203836/. Data as of 2026-11-06.